[go: up one dir, main page]

RU2012122468A - COMPOSITION FOR TREATMENT OF SKIN INJURIES - Google Patents

COMPOSITION FOR TREATMENT OF SKIN INJURIES Download PDF

Info

Publication number
RU2012122468A
RU2012122468A RU2012122468/15A RU2012122468A RU2012122468A RU 2012122468 A RU2012122468 A RU 2012122468A RU 2012122468/15 A RU2012122468/15 A RU 2012122468/15A RU 2012122468 A RU2012122468 A RU 2012122468A RU 2012122468 A RU2012122468 A RU 2012122468A
Authority
RU
Russia
Prior art keywords
composition
ointment base
lanolin
treatment
phenol
Prior art date
Application number
RU2012122468/15A
Other languages
Russian (ru)
Other versions
RU2539378C2 (en
Inventor
Виталий Владиславович Радченко
Маргарита Владимировна Александрова
Татьяна Маратовна Шуваева
Елена Вячеславовна Ильницкая
Владимир Иванович Новоселов
Марс Галиевич Шарапов
Original Assignee
Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) filed Critical Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН)
Priority to RU2012122468/15A priority Critical patent/RU2539378C2/en
Publication of RU2012122468A publication Critical patent/RU2012122468A/en
Application granted granted Critical
Publication of RU2539378C2 publication Critical patent/RU2539378C2/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Состав для лечения повреждений кожи, включающий лекарственное средство и мазевую основу, отличающийся тем, что в качестве лекарственного средства он содержит суспензию микробных клеток непатогенного бесплазмидного штамма Еcoliпроизводящих рекомбинантный пероксиредоксин 6 человека идентичный по аминокислотной последовательности природному белку, а мазевая основа содержит вазелин, ланолин, физиологический раствор и фенол в качестве консерванта при следующем соотношении компонентов, г:A composition for treating skin lesions, including a drug and an ointment base, characterized in that it contains a suspension of microbial cells of a non-pathogenic non-plasmid strain Еcoli producing recombinant human peroxyredoxin 6 identical in amino acid sequence to a natural protein, and the ointment base contains vaseline, lanolin, physiological solution and phenol as a preservative in the following ratio of components, g:

Claims (1)

Состав для лечения повреждений кожи, включающий лекарственное средство и мазевую основу, отличающийся тем, что в качестве лекарственного средства он содержит суспензию микробных клеток непатогенного бесплазмидного штамма Е. coli, производящих рекомбинантный пероксиредоксин 6 человека идентичный по аминокислотной последовательности природному белку, а мазевая основа содержит вазелин, ланолин, физиологический раствор и фенол в качестве консерванта при следующем соотношении компонентов, г:Composition for the treatment of skin lesions comprising a drug and an ointment base, characterized in that as a drug it comprises a suspension of microbial cells besplazmidnogo non-pathogenic strain of E. coli, producing a recombinant human peroxiredoxin 6 identical in amino acid sequence to the natural protein, and ointment base comprises petrolatum, lanolin, saline and phenol as a preservative in the following ratio, g: суспензия микробных клеток штамма-продуцентаmicrobial suspension of producer strain   в физиологическом растворе, содержащаяin saline containing   не менее 330 млн. клетокno less than 330 million cells 150-200 мг150-200 mg фенолphenol 5 мг5 mg смесь 5 частей вазелина аптечного и 2 частей ланолинаa mixture of 5 parts of Vaseline pharmacy and 2 parts of lanolin до 1 гup to 1 g
RU2012122468/15A 2012-05-31 2012-05-31 Formulation for treating skin damages RU2539378C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2012122468/15A RU2539378C2 (en) 2012-05-31 2012-05-31 Formulation for treating skin damages

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2012122468/15A RU2539378C2 (en) 2012-05-31 2012-05-31 Formulation for treating skin damages

Publications (2)

Publication Number Publication Date
RU2012122468A true RU2012122468A (en) 2013-12-10
RU2539378C2 RU2539378C2 (en) 2015-01-20

Family

ID=49682661

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012122468/15A RU2539378C2 (en) 2012-05-31 2012-05-31 Formulation for treating skin damages

Country Status (1)

Country Link
RU (1) RU2539378C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000005467A1 (en) * 2020-03-13 2021-09-13 Univ Degli Studi Di Roma “Tor Vergata” Peroxiredoxin 6 or a synthetic analogue thereof for use as a hypoglycemic agent.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2280448C2 (en) * 2002-11-10 2006-07-27 Институт биофизики клетки РАН Composition with antioxidant property and method for treatment of disease in mammals

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000005467A1 (en) * 2020-03-13 2021-09-13 Univ Degli Studi Di Roma “Tor Vergata” Peroxiredoxin 6 or a synthetic analogue thereof for use as a hypoglycemic agent.
WO2021181436A1 (en) * 2020-03-13 2021-09-16 Università Degli Studi di Roma "Tor Vergata" Peroxiredoxin 6 or a synthetic analogue thereof for use as a hypoglycaemic agent

Also Published As

Publication number Publication date
RU2539378C2 (en) 2015-01-20

Similar Documents

Publication Publication Date Title
MX2019000586A (en) Treatment of amd using aav sflt-1.
EA201490512A1 (en) COMPOSITIONS CONTAINING CULTIVATED IN ANAEROBIC CONDITIONS HUMAN INTESTINE MICROBIOT
CY1118073T1 (en) COMPOSITIONS AND METHODS FOR INCREASING THE TELECOMMUNICATION ACT
MA40057A (en) Therapeutic tratment of skin disease with recombinant commensal skin microorganisms
EP4124346A3 (en) Compositions and methods for treating diseases
EA200702523A1 (en) APPLICATION OF ERYTHROPOIETHIN IN LOW DOSAGE FOR STIMULATION OF ENDOTHELIAL CELLS PRECONDENTS, AND ALSO FOR REGENERATION OF ORGANS AND SLOWING PROGRESSION OF DAMAGES OF FINAL ORGANS
EA201300062A1 (en) PHARMACEUTICAL COMPOSITION, INTENDED FOR THE TREATMENT OF DISEASES OF THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF VASCULAR, TRAUMATIC, TOXIC, HYPOXIC AND AUTOMOMMUNE
EA201591108A1 (en) HUMAN GROWTH HORMON AND ALBUMIN, COMPOSITIONS AND THEIR APPLICATIONS
EA201391063A1 (en) APOLIPOPROTEIN A-IV AS ANTIDIABETIC PEPTIDE
EA200800397A1 (en) TIZANIDINE COMPOSITIONS AND TREATMENT METHODS USING COMPOSITIONS
RU2012122468A (en) COMPOSITION FOR TREATMENT OF SKIN INJURIES
WO2012075244A3 (en) Use of hemoglobin effectors to increase the bioavailability of therapeutic gases
MX2023010918A (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES.
MX2022014888A (en) Mono- and bis-nitrosylated propanediols for therapeutic use.
RU2012136775A (en) METHOD AND MEANS FOR INCREASING ADAPTIVE POSSIBILITIES OF AN ATHLETES ORGANISM DURING THE TRAINING PROCESS
RU2010114841A (en) SELF-CONTAINING DRUG FOR PREVENTION AND TREATMENT OF MICROELEMENTOSIS IN AGRICULTURAL ANIMALS AND BIRDS
EA202190798A1 (en) ROTAMERIC ISOMERS OF 4-ALKYL-5-HETEROARYL-3H-1,2-DITHIOL-3-THIONES
RU2008113403A (en) DRUG FOR PROCESSING ORGANIC WASTE "ECOS"
EA201591095A1 (en) PROTEIN SLURP-1 FOR USE IN THE TREATMENT OF EYE DISEASES
EA201200753A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF URINARY BUBBLE DISEASES
RU2014144507A (en) METHOD AND MEANS FOR TREATING AN ACID DISEASE
RU2008100977A (en) "DIARON" PREPARATION FOR TREATMENT OF ACUTE GASTROINTESTINAL DISEASES OF NEWBORN CALVES
BRPI0602179A (en) pharmaceutical composition comprising cyclobenzaprine and aceclofenac in combination
Xia et al. A Remote-Controlled Nanopump Delivers Oxygen to Boost Energy Production in Osteoarthritis
RU2010126820A (en) PREBIOTIC, STIMULATING VAGINAL LACTOFLORA GROWTH

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20170601